Last Updated: November 8, 2026

Litigation Details for In Re: PersonalWeb Technologies, LLC (N.D. Cal. 2018)

« Back to Dashboard


Small Molecule Drugs cited in In Re: PersonalWeb Technologies, LLC
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

In Re: PersonalWeb Technologies, LLC, 5:18-md-02834: Litigation Summary and Patent Analysis

Last updated: November 4, 2026

The PersonalWeb multidistrict litigation ended with dismissal of the customer suits based primarily on the Kessler doctrine and claim-preclusion principles arising from earlier litigation against Amazon. The Federal Circuit affirmed the central result in PersonalWeb Technologies LLC v. Patreon, Inc., holding that PersonalWeb could not relitigate infringement claims against Amazon customers based on the same accused Amazon technology after Amazon had obtained a prior noninfringement judgment. The litigation also generated substantial fee exposure for PersonalWeb.

What is In Re: PersonalWeb Technologies, LLC, 5:18-md-02834?

In re: PersonalWeb Technologies, LLC was a multidistrict patent proceeding in the U.S. District Court for the Northern District of California. The proceeding consolidated numerous infringement actions filed by PersonalWeb against companies that used Amazon Web Services technology.

The litigation centered on PersonalWeb's allegations that Amazon customers infringed patents covering systems for assigning content-dependent identifiers to data files and using those identifiers in data storage and management.

Item Details
MDL docket No. 5:18-md-02834
Court U.S. District Court for the Northern District of California
Consolidation 2018
Plaintiff PersonalWeb Technologies LLC
Primary technology Content-dependent file identification and data management
Accused platform Amazon Web Services, including S3-related functionality
Representative defendant Patreon, Inc.
Appellate decision PersonalWeb Technologies LLC v. Patreon, Inc., 951 F.3d 1307 (Fed. Cir. 2020)
Core disposition Dismissal based on claim preclusion and the Kessler doctrine
Current posture Merits litigation closed

The MDL did not involve a pharmaceutical product, FDA exclusivity, Orange Book listing, biosimilar pathway, or generic-drug entry risk. Its commercial significance was concentrated in cloud-computing infrastructure, customer litigation exposure, and the use of prior supplier litigation to protect downstream customers.

Which patents did PersonalWeb assert?

PersonalWeb asserted a patent family directed to content-addressable data storage and file-identification techniques. The principal patents included:

Patent General subject matter Litigation significance
U.S. Patent No. 6,928,442 Content-dependent naming and data processing Asserted in the earlier Amazon litigation and later customer suits
U.S. Patent No. 7,802,310 Related data-processing and file-identification techniques Asserted against Amazon customers
U.S. Patent No. 8,078,646 Continuation-family technology involving content-based identification Asserted in the customer litigation

PersonalWeb's infringement theory was tied to Amazon's use of content-dependent identifiers in services such as Amazon S3. The company alleged that customers infringed by using Amazon's services, rather than by independently practicing a materially different technology.

The Federal Circuit treated the accused Amazon functionality as central to the analysis. The asserted claims, the accused AWS technology, and the prior Amazon judgment were sufficiently connected to trigger the Kessler doctrine. (PersonalWeb, 951 F.3d at 1312-18.)

What technology was at issue?

The patents generally concerned the use of a file's content to generate an identifier or name. That approach can allow a system to recognize identical content, manage versions, and avoid treating duplicate content as unrelated files.

The customer suits did not principally challenge independent customer-developed software. They targeted the customers' use of AWS functionality. That distinction was critical. The Federal Circuit viewed the customers' alleged infringement as dependent on the same technology that PersonalWeb had previously litigated against Amazon.

What earlier Amazon litigation controlled the MDL?

PersonalWeb previously sued Amazon in the Eastern District of Texas. Amazon obtained a judgment that prevented PersonalWeb from pursuing the same infringement theory against Amazon.

The earlier litigation produced a final judgment that Amazon's accused technology did not infringe the asserted claims. The Federal Circuit affirmed the relevant judgment, and the Supreme Court denied review. PersonalWeb later attempted to pursue infringement claims against Amazon's customers based on their use of the same AWS technology.

The sequence was:

Period Event
2000s PersonalWeb litigated related patent claims against Amazon
2011 Federal Circuit affirmed the key Amazon judgment
2018 PersonalWeb filed numerous customer suits
2018 The customer cases were centralized in MDL No. 5:18-md-02834
2019 The district court dismissed the customer actions
2020 The Federal Circuit affirmed the dismissal in PersonalWeb v. Patreon
After 2020 Fee and sanctions disputes continued, but the merits theory did not revive

Why did the court apply the Kessler doctrine?

The Kessler doctrine protects a prevailing accused product or process from repeated infringement litigation after a final judgment. It originated in Kessler v. Eldred, 206 U.S. 285 (1907), and prevents a patent owner from using later suits against customers or other parties to relitigate the same infringement dispute indirectly.

The Federal Circuit held that the doctrine applied because:

  1. Amazon had previously obtained a judgment concerning the relevant technology.
  2. The customer suits were based on the same AWS functionality.
  3. PersonalWeb's theory against the customers depended on the same alleged acts previously litigated against Amazon.
  4. Allowing the suits to proceed would undermine Amazon's right to use and sell the technology without repeated infringement claims.

The doctrine did not require the customers to have been parties to the original Amazon case. That was the principal legal issue. The Federal Circuit held that the Kessler doctrine can protect a product or process and those who use it even when the later defendant was not a party to the earlier action. (PersonalWeb, 951 F.3d at 1316-21.)

How did Kessler differ from ordinary claim preclusion?

Ordinary claim preclusion generally requires identity or privity between the parties in the two actions. PersonalWeb argued that Amazon's customers were not parties to the earlier Amazon litigation and therefore could not invoke claim preclusion.

The Federal Circuit relied on the Kessler doctrine as an independent basis for dismissal. Kessler focuses on the legal status of the accused product or process after a favorable judgment. It prevents a patent owner from obtaining a different result by suing users of the same technology instead of the original manufacturer.

This distinction expanded the practical protection available to Amazon and its customers.

What did the Federal Circuit decide in PersonalWeb v. Patreon?

The Federal Circuit affirmed the district court's dismissal of the customer suits. The court held that PersonalWeb's claims were barred because they sought to impose infringement liability based on AWS functionality that had already been adjudicated in Amazon's favor.

The court rejected PersonalWeb's argument that later suits involved different defendants and therefore presented new controversies. The relevant question was whether the new suits sought to challenge the same protected technology.

The appellate decision established several important points:

  • A prior judgment involving a technology supplier can protect downstream customers.
  • The Kessler doctrine can apply even where traditional claim preclusion requirements are not fully satisfied.
  • A patent owner cannot evade a prior noninfringement judgment by changing defendants while relying on the same accused functionality.
  • Customer litigation based on use of a supplier's adjudicated technology can be dismissed at an early stage.

The Federal Circuit's decision is frequently cited in cases involving software platforms, cloud services, component suppliers, and customer suits.

What was the litigation status of the MDL?

The merits of the MDL were resolved in favor of the defendants. The customer cases did not proceed to a consolidated infringement trial.

The dismissal eliminated the immediate infringement exposure for the participating AWS customers based on the asserted theory. It also reduced the likelihood that PersonalWeb could continue filing substantially identical suits against additional AWS users.

The case did not produce:

  • A finding that the asserted patents were invalid in a trial on the merits.
  • A damages verdict against an AWS customer.
  • A permanent injunction against AWS customers.
  • A settlement-driven licensing framework for the broader customer base.
  • A generic or biosimilar entry issue.

The dispositive protection came from preclusion principles and the earlier Amazon judgment, not from a full invalidity trial.

Did PersonalWeb face attorneys' fees or sanctions?

Yes. The litigation generated fee and sanctions disputes because defendants argued that PersonalWeb continued pursuing claims after the preclusive effect of the Amazon judgment became clear.

Under 35 U.S.C. § 285, a court may award reasonable attorneys' fees in an exceptional patent case. The district court found grounds for fee shifting in connection with the customer litigation. The Federal Circuit's treatment of the fee and sanctions issues was separate from its core holding affirming dismissal.

The financial effect was material. Public reporting and court filings described fee exposure in the multimillion-dollar range, including an award exceeding $5 million in related proceedings. The fee rulings increased the risk of pursuing repetitive customer litigation after an adverse supplier judgment.

For patent owners, the case demonstrates that a noninfringement judgment can create both substantive preclusion risk and fee-shifting risk. For technology customers, it provides a basis for seeking early dismissal and recovery of defense costs.

Which companies challenged PersonalWeb's infringement claims?

The MDL involved numerous companies that used Amazon's cloud services. Publicly identified defendants included Patreon and other technology, media, and internet companies. The litigation was directed at AWS users rather than only at Amazon.

The important competitive division was:

Stakeholder Litigation position
PersonalWeb Patent owner pursuing customer infringement claims
Amazon Prior defendant with a favorable judgment concerning the accused AWS technology
AWS customers Downstream defendants asserting preclusion and Kessler defenses
District court Centralized and dismissed the customer cases
Federal Circuit Affirmed the principal dismissal ruling

The decision strengthened the position of cloud-service providers whose customers face patent claims based on use of hosted infrastructure.

What generic launch or regulatory risks existed?

No pharmaceutical generic-launch risk existed. The relevant commercial risk was technology-user litigation.

The decision reduced three types of exposure for AWS customers:

  1. Litigation costs from duplicative patent suits.
  2. Potential royalties or damages based on use of AWS services.
  3. Operational disruption from injunction requests targeting customer use of cloud infrastructure.

The decision also created a litigation-management advantage for platform providers. A supplier that obtains a final noninfringement judgment may be able to extend that protection to customers using the same accused platform.

How strong was PersonalWeb's patent estate after the MDL?

The patent estate had technical breadth across related content-identification and data-management claims, but its enforcement position was materially weakened by the Amazon judgment and the Federal Circuit's Kessler ruling.

Strength factor Assessment
Technical scope Broad enough to support repeated claims involving content-dependent identifiers
Family depth Multiple related patents and continuation claims
Prior adjudication Significant weakness because the relevant AWS functionality had already been litigated
Customer enforcement Severely constrained by Kessler
Invalidity ruling Not the primary basis for the MDL disposition
Licensing leverage Reduced after dismissal and fee exposure
Geographic reach U.S. litigation only in the reported proceedings

The case shows that patent strength cannot be assessed only by claim language or family size. A prior judgment involving the same accused technology can limit enforcement against an entire customer ecosystem.

What is the current litigation and settlement status?

The MDL's infringement claims are closed following dismissal and appellate affirmance. No broad settlement agreement is the principal public basis for the disposition. The operative result came from judicial rulings applying claim-preclusion and Kessler principles.

Any later enforcement would face substantial obstacles if it relies on the same AWS functionality and the same patent claims or materially identical claims. A materially different accused product, different patent claim, or new post-judgment conduct could present a different analysis, but the PersonalWeb decision sharply limits attempts to repackage the same dispute.

Key Takeaways

  • MDL No. 5:18-md-02834 consolidated PersonalWeb's patent suits against Amazon customers.
  • The asserted technology involved content-dependent data identification and storage.
  • PersonalWeb had previously litigated related infringement claims against Amazon.
  • The district court dismissed the customer cases based on claim preclusion and the Kessler doctrine.
  • The Federal Circuit affirmed in PersonalWeb Technologies LLC v. Patreon, Inc., 951 F.3d 1307 (Fed. Cir. 2020).
  • The ruling allows a favorable supplier judgment to protect downstream customers using the same technology.
  • The case created substantial fee exposure for repetitive customer litigation.
  • The merits litigation is closed, and no pharmaceutical exclusivity, Orange Book, biosimilar, or generic-entry issue is involved.

FAQs About In Re: PersonalWeb Technologies, LLC

Can a cloud customer use the Kessler doctrine if it was not involved in the original patent case?

Yes. PersonalWeb held that the doctrine can protect customers that were not parties to the earlier case when the later claims target the same technology covered by the prior favorable judgment.

Did PersonalWeb lose because its patents were invalid?

No. The principal disposition rested on claim-preclusion and Kessler principles tied to the prior Amazon judgment. The MDL was not resolved primarily through a full invalidity trial.

Does the PersonalWeb decision protect every AWS customer from every patent claim?

No. The protection is tied to the same adjudicated technology, claims, and infringement theory. A materially different product, patent, or post-judgment activity could require separate analysis.

Can a patent owner sue a customer after losing against the customer's technology supplier?

The owner may attempt to file such a suit, but PersonalWeb shows that the customer can seek early dismissal where the suit repackages the same infringement dispute. Fee exposure may also increase.

What is the main business lesson from the PersonalWeb MDL?

A technology supplier's favorable patent judgment can have ecosystem-wide value. It may protect customers, reduce litigation duplication, and shift the supplier's patent risk from individual users to a single central proceeding.

References

Federal Circuit. (2020). PersonalWeb Technologies LLC v. Patreon, Inc., 951 F.3d 1307. U.S. Court of Appeals for the Federal Circuit.

Northern District of California. (2018-2020). In re: PersonalWeb Technologies, LLC Patent Litigation, No. 5:18-md-02834. U.S. District Court for the Northern District of California.

Supreme Court of the United States. (2011). PersonalWeb Technologies LLC v. Amazon.com, Inc., certiorari denial following Federal Circuit proceedings.

United States Congress. (2023). 35 U.S.C. § 285, exceptional cases and attorneys' fees.

  • Kessler v. Eldred*, 206 U.S. 285 (1907).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.